Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049) - Image 1

£122.85

Springer Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)

Name: Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)
Brand: Springer
Price: 122.85 GBP
Availability: InStock

Neurology & Clinical Neurophysiology

Same price for 16 weeks. Today is much like next week.

£123 for 111 days straight · last change was Aug 2025

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 552 days • 552 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 552 days • 8 price levels

Days at Price

Current Price

Price Analysis

Most common price: £132 (190 days, 34.4%)

Price range: £108 - £132

Price levels: 8 different prices over 552 days

Description

This book provides a cutting-edge review of polyglutamine disorders. It primarily focuses on two main aspects: (1) the mechanisms underlying the pathologies’ development and progression, and (2) the therapeutic strategies that are currently being explored to stop or delay disease progression. Polyglutamine (polyQ) disorders are a group of inherited neurodegenerative diseases with a fatal outcome that are caused by an abnormal expansion of a coding trinucleotide repeat (CAG), which is then translated in an abnormal protein with an elongated glutamine tract (Q). To date, nine polyQ disorders have been identified and described: dentatorubral-pallidoluysian atrophy (DRPLA); Huntington’s disease (HD); spinal–bulbar muscular atrophy (SBMA); and six spinocerebellar ataxias (SCA 1, 2, 3, 6, 7, and 17). The genetic basis of polyQ disorders is well established and described, and despite important advances that have opened up the possibility of generating genetic models of the disease, the mechanisms that cause neuronal degeneration are still largely unknown and there is currently no treatment available for these disorders. Further, it is believed that the different polyQ may share some mechanisms and pathways contributing to neurodegeneration and disease progression. From the Back Cover This book provides a cutting-edge review of polyglutamine disorders. It primarily focuses on two main aspects: (1) the mechanisms underlying the pathologies’ development and progression, and (2) the therapeutic strategies that are currently being explored to stop or delay disease progression. Polyglutamine (polyQ) disorders are a group of inherited neurodegenerative diseases with a fatal outcome that are caused by an abnormal expansion of a coding trinucleotide repeat (CAG), which is then translated in an abnormal protein with an elongated glutamine tract (Q). To date, nine polyQ disorders have been identified and described: dentatorubral-pallidoluysian atrophy (DRPLA); Huntington’s disease (HD); spinal–bulbar muscular atrophy (SBMA); and six spinocerebellar ataxias (SCA 1, 2, 3, 6, 7, and 17). The genetic basis of polyQ disorders is well established and described, and despite important advances that have opened up the possibility of generating genetic models of the disease, the mechanisms that cause neuronal degeneration are still largely unknown and there is currently no treatment available for these disorders. Further, it is believed that the different polyQ may share some mechanisms and pathways contributing to neurodegeneration and disease progression. About the Author Clevio Nobrega Ph.D. and Luis Pereira de Almeida Ph.D. University of Coimbra, Center for Neurosciences and Cell Biology, FMUC, Coimbra, Portugal

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3319717782
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 20 February 2018
Listed Since: 26 October 2017

Barcode

No barcode data available

Springer Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)

Same price for 16 weeks. Today is much like next week.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Neurobiology of Huntington’s Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

Huntington’s Disease: Pathogenic Mechanisms and Implications for Therapeutics

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

SPEC – Handbook of Clinical Neurology, Volume 144, Huntington Disease, 12-Month Access, eBook (Volume 144)

Food for Huntingtons Disease (Nutrition and Diet Research Pr)

Parkinson's Disease and Related Disorders Part I (Volume 83) (Handbook of Clinical Neurology, Volume 83)

Huntington's Disease: Etiology & Symptoms, Diagnosis & Treatment (Neuroscience Research Progress)

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

Movement Disorders: Genetics and Models

Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease

Animal Models of Movement Disorders: Volume II: 62 (Neuromethods)

The Basal Ganglia IX: 58 (Advances in Behavioral Biology, 58)

Insights into Human Neurodegeneration: Lessons Learnt from Drosophila

Cerebellar Degenerations: Clinical Neurobiology: 2 (Foundations of Neurology, 2)

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, Seventh Edition: Volume 2 (Volume 2)

The Molecular and Cellular Basis of Neurodegenerative Diseases: Underlying Mechanisms

Motor Neuron Disorders and Related Diseases (Volume 82) (Handbook of Clinical Neurology, Volume 82)

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Fundamentals of Neurodegeneration and Protein Misfolding Disorders (Biological and Medical Physics, Biomedical Engineering)

Fundamentals of Neurodegeneration and Protein Misfolding Disorders (Biological and Medical Physics, Biomedical Engineering)

Molecular Pathology of the Prions: 59 (Methods in Molecular Medicine)